Mirati Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Mirati Therapeutics shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Mirati Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mirati Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Mirati Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.2M | 38k | 58.77 |
2023-09-30 | $106M | 2.4M | 43.56 |
2023-06-30 | $64M | 1.8M | 36.13 |
2023-03-31 | $66M | 1.8M | 37.18 |
2022-12-31 | $64M | 1.4M | 45.31 |
2022-03-31 | $135M | 1.6M | 82.22 |
2021-12-31 | $319M | 2.2M | 146.69 |
2021-09-30 | $374M | 2.1M | 176.91 |
2021-06-30 | $310M | 1.9M | 161.53 |
2021-03-31 | $263M | 1.5M | 171.30 |
2020-12-31 | $343M | 1.6M | 219.64 |
2020-09-30 | $218M | 1.3M | 166.05 |
2020-06-30 | $149M | 1.3M | 114.17 |
2020-03-31 | $99M | 1.3M | 76.87 |
2019-12-31 | $179M | 1.4M | 128.86 |
2019-09-30 | $104M | 1.3M | 77.91 |
2019-06-30 | $124M | 1.2M | 103.00 |
2019-03-31 | $60M | 818k | 73.30 |
2018-12-31 | $14M | 329k | 42.42 |
2018-09-30 | $15M | 328k | 47.10 |
2018-06-30 | $11M | 213k | 49.30 |
2018-03-31 | $5.7M | 186k | 30.70 |